Nektar Therapeutics (NKTR)
72.22
-2.62
(-3.50%)
USD |
NASDAQ |
Mar 20, 16:00
72.35
+0.13
(+0.18%)
After-Hours: 20:00
Nektar Therapeutics EPS Diluted (Quarterly) : -1.778 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Eli Lilly & Co. | 7.024 |
| Rigel Pharmaceuticals, Inc. | 13.54 |
| Esperion Therapeutics, Inc. | 0.2173 |
| Insmed, Inc. | -1.538 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.08M |
| Revenue (Quarterly) | 21.81M |
| Total Expenses (Quarterly) | 57.89M |
| Enterprise Value | 1.153B |
| Gross Profit Margin (Quarterly) | 99.13% |
| Profit Margin (Quarterly) | -165.4% |
| Earnings Yield | -9.48% |
| Normalized Earnings Yield | -9.031 |